Navigation Links
Revalesio Initiates Phase IIa Study of RNS60 in Multiple Sclerosis at University Hospital Zurich
Date:11/11/2013

TACOMA, Wash., Nov. 11, 2013 /PRNewswire/ -- Revalesio Corporation is pleased to announce a new collaboration with noted neurologist Dr. Roland Martin, Head of Neuroimmunology and MS Research at the Department of Neurology, University Hospital Zurich. Dr. Martin will be conducting a Phase IIa clinical trial of RNS60 in patients with relapsing-remitting multiple sclerosis (RRMS or MS).  With 30 years experience, Dr. Martin is a recognized leader in the field of neuroimmunology and multiple sclerosis research.

The study will compare measurements of disease activity and progression in patients with RRMS during 6-months treatment with RNS60. The open label study will enroll 15 patients and evaluate the use of RNS60 by intravenous administration compared to patient's pre-treatment disease activity. The main outcome of the study will be the reduction of inflammatory activity in the brain as measured by Gd contrast-enhacing MRI lesions. Additional measures include progression of disability and biomarkers for RNS60 and general inflammation. The study will be conducted at the University Hospital Zurich in Switzerland and at Innsbruck Medical University in Innsbruck, Austria.

"Our MS development work with RNS60 has been an extraordinary process of discovery and pioneering research," said Dr. Richard Watson, Revalesio's Chief Science Officer. "We have published much of our data regarding RNS60's mechanisms in the pre-clinical models and are pleased to have Dr. Martin as a collaborator and to see RNS60 advance into the clinic for MS.  We are hopeful this study will provide an efficacy signal that demonstrates RNS60's therapeutic potential and informs future clinical research."

RNS60 has been tested in numerous pre-clinical models of MS and has shown the ability to halt disease progression by limiting glial
'/>"/>

SOURCE Revalesio Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Revalesio Presents Data Showing RNS60 Alters Disease Progression in Animal Model of Alzheimers Disease Through the PI3k-Akt Pathway
2. Perrigo Initiates Nationwide Voluntary Product Recall Of Acetaminophen Infant Suspension Liquid, 160 mg/5 mL, Due To A Potential Defect With The Co-Packaged Oral Syringe
3. Acacia Pharma Initiates Phase II Study With APD403 in Chemotherapy Induced Nausea & Vomiting (CINV)
4. Lumena Pharmaceuticals Initiates the CLARITY Phase II Study of LUM001 in Patients with Primary Biliary Cirrhosis
5. SeeThruEquity, LLC Initiates Coverage on Pressure BioSciences, Inc.
6. SWOG Initiates Randomized Phase 2 Clinical Trial of Halozymes PEGPH20 in Combination with modified FOLFIRINOX for Advanced Pancreatic Cancer
7. AstraZeneca Initiates Phase 3 Clinical Trial For Selumetinib In Non-Small Cell Lung Cancer
8. Edison initiates coverage of Derma Sciences
9. arGEN-X Initiates Phase IbStudy of ARGX-111 in Cancer
10. S&P Capital IQ Initiates Coverage on Epigenomics AG in Standard & Poors Factual Stock Reports
11. Selexys Pharmaceuticals Initiates SUSTAIN Phase 2 Clinical Trial in Sickle Cell Patients with Pain Crises
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 17, 2014  NuView Life Sciences, Inc. (NuView) ... collaboration agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka) ... diagnostic biomarker to detect cancers of the breast ... future diagnostic-imaging applications. NuView retains all rights for ... in-vitro urine screen applications. Under the ...
(Date:9/17/2014)... CITY, Kan. , Sept. 17, 2014  Aratana ... pet therapeutics company focused on licensing, developing and ... announced the pricing of its public offering of 4,500,000 shares ... the public of $9.25 per share. Aratana has ... up to an additional 675,000 shares of its ...
(Date:9/17/2014)... 17, 2014 Cardiac Dimensions ® , Inc. ... the TITAN II clinical trial of its enhanced ... improvements in mitral regurgitation, functional improvement, quality of ... and efficacy data, which was consistent with previous ... at the 26 th annual Transcatheter Cardiovascular ...
Breaking Medicine Technology:NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 2NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 3NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 4NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 5Aratana Therapeutics, Inc. Announces Pricing of Public Offering 2Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System 2Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System 3
... As previously announced, WebMD Health Corp. (Nasdaq: WBMD ) ... Annual Meetings of Stockholders beginning at 9:30 a.m. Eastern Time on ... of the meetings will be available over the Internet. To listen ... www.wbmd.com (in the Investor Relations section) or at ...
... Oct. 19 The board of directors of Eli Lilly and ... fourth quarter of 2009 of $0.49 a share on outstanding common ... the first three quarters of 2009 and brings the total annual ... http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO ) , The dividend is payable December ...
Cached Medicine Technology:WebMD and HLTH Corporation to Webcast Annual Meetings of Stockholders 2
(Date:9/17/2014)... The Oliver Law Group P.C. is urging ... Non-Sterile Other-Sonic Ultrasound Transmission Gel to contact the ... legal recourse. Other-Sonic ultrasound gel was recalled by the ... after the product was linked to a 2011 outbreak ... Royal Oak, Michigan . While victims of this outbreak ...
(Date:9/17/2014)... Tidewater Physical Therapy and ... for football players and their parents at its Newport ... open at 6:30 p.m. for athletes and parents to ... and physical therapists. The workshop will start at 7 ... News Tidewater Performance Center, which features sports performance and ...
(Date:9/17/2014)... The Scripps Research Institute (TSRI) have devised a ... effective against vancomycin-resistant strains of MRSA and other ... to have not one but two distinct mechanisms ... evolve resistance quickly. , "This is the prototype ... in clinical use a generation or maybe even ...
(Date:9/17/2014)... September 18, 2014 Many countries choose ... instead of immunizations. The total number of poultry exceeds ... to control, will result in huge losses. Therefore, it ... influenza vaccines. , Avian influenza vaccines have been used ... farms in China began to use H5N1 avian influenza ...
(Date:9/17/2014)... September 17, 2014 Why are Asian Americans at ... Americans, and prone to develop the disease at lower ... in the transition from traditional high-fiber, low-fat Asian diets ... for those of Asian heritage, says George King, M.D., ... Diabetes Center and the senior author of the study. ...
Breaking Medicine News(10 mins):Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 2Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 3Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 4Health News:Tidewater Physical Therapy and Performance Services and recruit757 To Host Football Scholarship Seminar 2Health News:Tidewater Physical Therapy and Performance Services and recruit757 To Host Football Scholarship Seminar 3Health News:Scripps Research Institute chemists modify antibiotic to vanquish resistant bacteria 2Health News:Scripps Research Institute chemists modify antibiotic to vanquish resistant bacteria 3Health News:China Avian Influenza Vaccine Industry 2014-2018 Research Report Now Available at LifeScienceIndustryResearch.com 2Health News:China Avian Influenza Vaccine Industry 2014-2018 Research Report Now Available at LifeScienceIndustryResearch.com 3Health News:In Joslin trial, Asian Americans lower insulin resistance on traditional diet 2Health News:In Joslin trial, Asian Americans lower insulin resistance on traditional diet 3
... not as interested in information on lifestyle changes , FRIDAY, ... the recent deluge of scientific discoveries of links between specific ... healthy people with something they don,t need: an excuse for ... people are going to use genetics as a way to ...
... Washington, are more likely to be obese if they ... a team of researchers at Seattle Children,s Research Institute, ... Institute. Social Science & Medicine e-published the ... The researchers found obesity most common in children ...
... Center for Neural Science, has been named the recipient ... work on how the brain reconstructs images, the Lisbon-based ... William T. Newsome, a Stanford University neuroscientist. ... prize, the largest monetary prize in the field of ...
... at the University of Leicester is examining a sequence of ... individual. This follows evidence that these structures shrink in ... to several diseases including those commonly associated with ageing and, ... study is trying to understand how this process is controlled. ...
... a youth club, they gain a stronger sense of who ... has revealed. The study suggests that even small improvements ... out of trouble. "The more kids participate in these ... an associate professor of social work at Ohio State. "And ...
... Genomics Consortium (SGC) and Pfizer today announced that Pfizer ... molecule inhibitors "chemical probes" for proteins involved ... now members of this collaboration, launched in late 2008 ... quality research reagents, free from restriction on use. ...
Cached Medicine News:Health News:Least Healthy More Apt to Think Genes Explain Disease Risk 2Health News:Least Healthy More Apt to Think Genes Explain Disease Risk 3Health News:Least Healthy More Apt to Think Genes Explain Disease Risk 4Health News:Childhood obesity linked to neighborhood social and economic status 2Health News:Childhood obesity linked to neighborhood social and economic status 3Health News:NYU's Movshon receives Champalimaud Vision Award for work on how brain reconstructs images 2Health News:Size matters -- when it comes to DNA 2Health News:Youth clubs strengthen kids' self image to keep them out of trouble 2Health News:Youth clubs strengthen kids' self image to keep them out of trouble 3Health News:Pfizer joins open-access medicinal chemistry public-private collaboration 2
Each handle is designed to fit a specific trephine size....
Reusable, stainless steel trephine with handle....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: